Teva Faces New Probe in Turkey Over Conduct Flagged by EU
Not a new theory of harm. It is the European Commission’s Copaxone decision run a second time, with two of the same corporate entities named.
Not a new theory of harm. It is the European Commission’s Copaxone decision run a second time, with two of the same corporate entities named.